Wedbush Keeps a Buy Rating on Clearside Biomedical (CLSD)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Clearside Biomedical (CLSD – Research Report), with a price target of $3.00. The company’s shares closed last Monday More »

Analysts Conflicted on These Technology Names: Mercadolibre (NASDAQ: MELI) and Advanced Micro Devices (NASDAQ: AMD)

Analysts have been eager to weigh in on the Technology sector with new ratings on Mercadolibre (MELI – Research Report) and Advanced Micro Devices (AMD – Research Report). Mercadolibre (MELI) In a More »